Last 12 months
Inside the activity.
6 purchase rows · 12 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 1 | 0 |
| Apr 2026 | 1 | 0 |
| May 2026 | 1 | 0 |
| Jun 2026 | 1 | 4 |
| Jul 2026 | 1 | 0 |
| Aug 2026 | 1 | 4 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 13, 2020 Filed Jan 20, 2023 21:32 UTC |
Knowles JuliusDirector
|
PurchaseCommon Stock | 1,191 | $20.98 | $24,987.18 |
DisclosureSEC source: 0001209191-23-004279 · doc4.xml · nonDerivative · entry 1 Knowles Julius · CIK 0001808365 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,191 Read SEC document |
| April 07, 2020 Filed Apr 8, 2020 21:01 UTC |
Ordonez ClaudiaChief Medical Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 18,430 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-023989 · doc4.xml · derivative · entry 1 Ordonez Claudia · CIK 0001808290 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,430 Underlying: Common Stock · 18,430 shares Expires 2030-04-06 F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option shall vest on March 1, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| April 07, 2020 Filed Apr 8, 2020 21:00 UTC |
Lachey JenniferChief Scientific Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 241,222 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-023988 · doc4.xml · derivative · entry 1 Lachey Jennifer · CIK 0001808322 · Chief Scientific Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 241,222 Underlying: Common Stock · 241,222 shares Expires 2030-04-06 F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option shall vest on March 1, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| April 07, 2020 Filed Apr 9, 2020 01:03 UTC |
Seehra JasbirDirector · Chief Executive Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 696,569 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-023991 · doc4.xml · derivative · entry 1 Seehra Jasbir · CIK 0001732369 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 696,569 Underlying: Common Stock · 696,569 shares Expires 2030-04-06 F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option shall vest on March 1, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| April 07, 2020 Filed Apr 9, 2020 01:02 UTC |
Regnante KeithChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 133,622 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-023990 · doc4.xml · derivative · entry 2 Regnante Keith · CIK 0001682068 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 133,622 Underlying: Common Stock · 133,622 shares Expires 2030-04-06 F2 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option shall vest on February 24, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
| April 07, 2020 Filed Apr 9, 2020 01:02 UTC |
Regnante KeithChief Financial Officer
|
GrantEmployee Stock Option (right to buy) · Derivative | 18,430 | $0.00 Strike: $16.00 | $0.00 |
DisclosureSEC source: 0001209191-20-023990 · doc4.xml · derivative · entry 1 Regnante Keith · CIK 0001682068 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,430 Underlying: Common Stock · 18,430 shares Expires 2030-04-06 F1 · derivative.exercise_date: One-fourth (1/4th) of the shares subject to the option shall vest on March 1, 2021, and one-twelfth (1/12th) of the remaining shares subject to the option shall vest in equal quarterly installments thereafter, subject to the Reporting Person continuing to provide service through each such date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.